At the recent Society for Immunotherapy of Cancer meeting, researchers from Dong-A ST Co. Ltd. presented preclinical data for the novel small-molecule general control nonderepressible 2 (GCN2) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback